Safe and successful surgery is resource-intensive, but it turns out that there's way more stuff in the operating room than necessary. And a lot of it goes unused.
Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to.
Individuals with intraductal papillary mucinous neoplasms that lack worrisome or high-risk features have no greater risk of pancreatic cancer than individuals without IPMNs.